{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:28Z","timestamp":1792175968836,"version":"4.4.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["ADITEC HEALTH-F4-2011-280873"],"award-info":[{"award-number":["ADITEC HEALTH-F4-2011-280873"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["TBVAC2020 (643381)"],"award-info":[{"award-number":["TBVAC2020 (643381)"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["Infect Control 2020\u201d (03ZZ0806A)"],"award-info":[{"award-number":["Infect Control 2020\u201d (03ZZ0806A)"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00121","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T08:00:43Z","timestamp":1517817643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":122,"title":["Next-Generation Vaccines Based on Bacille Calmette\u2013Gu\u00e9rin"],"prefix":"10.3389","volume":"9","author":[{"given":"Natalie E.","family":"Nieuwenhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H. E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2017","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1258\/0956462053057576","article-title":"Co-infection with HIV and TB: double trouble","volume":"16","author":"McShane","year":"2005","journal-title":"Int J STD AIDS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1378\/chest.14-0918","article-title":"Optimal duration of anti-TB treatment in patients with diabetes: nine or six months?","volume":"147","author":"Wang","year":"2015","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"Jacobson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"828939","DOI":"10.1155\/2013\/828939","article-title":"Risk factors for tuberculosis","volume":"2013","author":"Narasimhan","year":"2013","journal-title":"Pulm Med"},{"key":"B7","first-page":"1927","volume-title":"La vaccination pr\u00e9ventive contre la tuberculose par le \u201cBCG\u201d","author":"Calmette","year":"1927"},{"key":"B8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","author":"Bekkering","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"i5225","DOI":"10.1136\/bmj.i5225","article-title":"Non-specific immunological effects of selected routine childhood immunisations: systematic review","volume":"355","author":"Kandasamy","year":"2016","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies \u2013 a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2017.06.007","article-title":"BCG \u2013 old workhorse, new skills","volume":"47","author":"Gengenbacher","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","article-title":"TB vaccine development and the end TB strategy: importance and current status","volume":"110","author":"Fletcher","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijid.2017.01.024","article-title":"Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model","volume":"56","author":"Rao","year":"2017","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21390","article-title":"Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK","volume":"21","author":"Mangtani","year":"2017","journal-title":"Health Technol Assess"},{"key":"B20","doi-asserted-by":"publisher","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/S0034-89102007000800009","article-title":"[BCG vaccine against tuberculosis: its protective effect and vaccination policies]","volume":"41","author":"Pereira","year":"2007","journal-title":"Rev Saude Publica"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"B26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to bacillus Calmette-Guerin vaccination: why do they fail to protect against Mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/S0140-6736(15)00322-0","article-title":"Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment","volume":"386","author":"Yuen","year":"2015","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-3156.2010.02676.x","article-title":"Role of risk factors and socio-economic status in pulmonary tuberculosis: a search for the root cause in patients in a tertiary care hospital, South India","volume":"16","author":"Gupta","year":"2011","journal-title":"Trop Med Int Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e47533","DOI":"10.1371\/journal.pone.0047533","article-title":"Tuberculosis and poverty: why are the poor at greater risk in India?","volume":"7","author":"Oxlade","year":"2012","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0004232","DOI":"10.1371\/journal.pntd.0004232","article-title":"Comparative genomics of field isolates of Mycobacterium bovis and M. caprae provides evidence for possible correlates with bacterial viability and virulence","volume":"9","author":"de la Fuente","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.vaccine.2012.02.018","article-title":"Bovine tuberculosis vaccine research: historical perspectives and recent advances","volume":"30","author":"Waters","year":"2012","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.6.1.1-5.1999","article-title":"Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens","volume":"6","author":"Buddle","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1128\/JCM.00420-10","article-title":"Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals","volume":"48","author":"Whelan","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.rvsc.2009.05.022","article-title":"Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis","volume":"88","author":"Lopez-Valencia","year":"2010","journal-title":"Res Vet Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1128\/CVI.00222-10","article-title":"Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia","volume":"17","author":"Ameni","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"Lindenstrom","year":"2013","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant bacillus Calmette-Guerin DeltaureC:hly vaccine\u2019s superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1686","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"MBio"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mi.2016.105","article-title":"IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis","volume":"10","author":"Venkatasubramanian","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.smim.2014.09.006","article-title":"BCG-induced protection: effects on innate immune memory","volume":"26","author":"Netea","year":"2014","journal-title":"Semin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.12276","article-title":"B cells and antibodies in the defense against Mycobacterium tuberculosis infection","volume":"264","author":"Achkar","year":"2015","journal-title":"Immunol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1600-065X.2010.00994.x","article-title":"For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection","volume":"240","author":"Dorhoi","year":"2011","journal-title":"Immunol Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1016\/j.vaccine.2014.10.041","article-title":"Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis","volume":"32","author":"Kaveh","year":"2014","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e113951","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","author":"Nandakumar","year":"2014","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"B56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis (Edinb)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0009-2016","article-title":"The memory immune response to tuberculosis","volume":"4","author":"Kirman","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","article-title":"ESX\/type VII secretion systems and their role in host-pathogen interaction","volume":"12","author":"Simeone","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1371\/journal.ppat.0030110","article-title":"Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells","volume":"3","author":"Velmurugan","year":"2007","journal-title":"PLoS Pathog"},{"key":"B62","doi-asserted-by":"publisher","first-page":"19408","DOI":"10.1073\/pnas.1006298107","article-title":"Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection","volume":"107","author":"Reiley","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tube.2015.11.008","article-title":"KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults","volume":"97","author":"Boer","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1: PD-ligand 1\/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/1040841X.2016.1185603","article-title":"T-cell exhaustion in tuberculosis: pitfalls and prospects","volume":"43","author":"Khan","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1006704","DOI":"10.1371\/journal.ppat.1006704","article-title":"Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis","volume":"13","author":"Carpenter","year":"2017","journal-title":"PLoS Pathog"},{"key":"B67","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.chom.2014.05.007","article-title":"Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming","volume":"15","author":"Srivastava","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B68","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1038\/ncomms13894","article-title":"Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy","volume":"7","author":"Griffiths","year":"2016","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1128\/IAI.00550-12","article-title":"Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset","volume":"80","author":"Lindenstrom","year":"2012","journal-title":"Infect Immun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/mi.2016.110","article-title":"Vaccination for Mycobacterium tuberculosis infection: reprogramming CD4 T-cell homing into the lung","volume":"10","author":"Barber","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.vaccine.2009.09.121","article-title":"Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs","volume":"28","author":"Dey","year":"2009","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2017.1279771","article-title":"Immunogenicity and protective efficacy of recombinant bacille Calmette-Guerin strains expressing Mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70","volume":"13","author":"Dai","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"B80","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1007\/s00253-015-6962-x","article-title":"A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection","volume":"99","author":"Yuan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1128\/IAI.00267-10","article-title":"Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice","volume":"78","author":"Sali","year":"2010","journal-title":"Infect Immun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","author":"Bottai","year":"2015","journal-title":"Vaccine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection","volume":"18","author":"Groschel","year":"2017","journal-title":"Cell Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/IAI.62.6.2508-2514.1994","article-title":"Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes","volume":"62","author":"O\u2019Donnell","year":"1994","journal-title":"Infect Immun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2249.2004.02522.x","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity","volume":"137","author":"Luo","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1128\/IAI.70.12.6549-6557.2002","article-title":"Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice","volume":"70","author":"Biet","year":"2002","journal-title":"Infect Immun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1440-1711.2002.01078.x","article-title":"Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin","volume":"80","author":"Young","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/mpat.2000.0382","article-title":"Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity","volume":"29","author":"Moreira","year":"2000","journal-title":"Microb Pathog"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1086\/586902","article-title":"Efficacy of recombinant bacille Calmette-Guerin vaccine secreting interleukin-15\/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis","volume":"197","author":"Tang","year":"2008","journal-title":"J Infect Dis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1348-0421.2010.00232.x","article-title":"Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL\/6 mice","volume":"54","author":"Shen","year":"2010","journal-title":"Microbiol Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1574-695X.2007.00322.x","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice","volume":"51","author":"Xu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3892\/mmr.2016.5447","article-title":"Ipr1 modified BCG as a novel vaccine induces stronger immunity than BCG against tuberculosis infection in mice","volume":"14","author":"Wang","year":"2016","journal-title":"Mol Med Rep"},{"key":"B94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/IAI.00897-06","article-title":"Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection","volume":"75","author":"Ryan","year":"2007","journal-title":"Infect Immun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e00679-16","DOI":"10.1128\/mBio.00679-16","article-title":"Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG DeltaureC::hly improves protection against tuberculosis","volume":"7","author":"Gengenbacher","year":"2016","journal-title":"MBio"},{"key":"B97","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.micinf.2016.03.005","article-title":"Post-exposure vaccination with the vaccine candidate bacillus Calmette-Guerin DeltaureC::hly induces superior protection in a mouse model of subclinical tuberculosis","volume":"18","author":"Gengenbacher","year":"2016","journal-title":"Microbes Infect"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1016\/j.vaccine.2011.07.144","article-title":"Improved long-term protection against Mycobacterium tuberculosis Beijing\/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens","volume":"29","author":"Reece","year":"2011","journal-title":"Vaccine"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e1262","DOI":"10.1128\/mBio.01262-14","article-title":"Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guerin DeltaureC::hly Deltapdx1 in mice","volume":"5","author":"Gengenbacher","year":"2014","journal-title":"MBio"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e78966","DOI":"10.1371\/journal.pone.0078966","article-title":"The tuberculosis vaccine candidate bacillus Calmette-Guerin DeltaureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice","volume":"8","author":"Rao","year":"2013","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/s41598-017-02003-9","article-title":"Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis","volume":"7","author":"Nascimento","year":"2017","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-3083.2009.02312.x","article-title":"Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans","volume":"70","author":"Parkash","year":"2009","journal-title":"Scand J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"B107","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1086\/345862","article-title":"Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation","volume":"187","author":"Lewis","year":"2003","journal-title":"J Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tim.2004.09.007","article-title":"ESAT-6 proteins: protective antigens and virulence factors?","volume":"12","author":"Brodin","year":"2004","journal-title":"Trends Microbiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1365-2249.1996.d01-613.x","article-title":"Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis","volume":"103","author":"Roche","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1172\/jci84978","article-title":"ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo","volume":"126","author":"Kupz","year":"2016","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1038\/ncomms16085","article-title":"Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis","volume":"8","author":"Aguilo","year":"2017","journal-title":"Nat Commun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2014.00321","article-title":"The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis","volume":"5","author":"Huygen","year":"2014","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrmicro.2016.131","article-title":"ESX secretion systems: mycobacterial evolution to counter host immunity","volume":"14","author":"Groschel","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"B115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1586\/14760584.2015.1068124","article-title":"Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy","volume":"14","author":"Zheng","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B116","doi-asserted-by":"publisher","first-page":"728930","DOI":"10.1155\/2011\/728930","article-title":"Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guerin and prospective use in immunotherapy of bladder cancer","volume":"2011","author":"Luo","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nature03419","article-title":"Ipr1 gene mediates innate immunity to tuberculosis","volume":"434","author":"Pan","year":"2005","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille Calmette-Guerin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1128\/IAI.72.7.4200-4209.2004","article-title":"Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface","volume":"72","author":"Sendide","year":"2004","journal-title":"Infect Immun"},{"key":"B121","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1128\/jb.177.19.5644-5652.1995","article-title":"Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction","volume":"177","author":"Clemens","year":"1995","journal-title":"J Bacteriol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1128\/IAI.06195-11","article-title":"Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism","volume":"80","author":"Lin","year":"2012","journal-title":"Infect Immun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tim.2012.04.006","article-title":"Listeriolysin O: the Swiss army knife of Listeria","volume":"20","author":"Hamon","year":"2012","journal-title":"Trends Microbiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiu675","article-title":"The recombinant BCG DeltaureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation","volume":"211","author":"Saiga","year":"2015","journal-title":"J Infect Dis"},{"key":"B125","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG DeltaureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e1370","DOI":"10.1128\/mBio.01370-16","article-title":"Sleeping beauty and the story of the bacille Calmette-Guerin vaccine","volume":"7","author":"Fletcher","year":"2016","journal-title":"MBio"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e1000864","DOI":"10.1371\/journal.ppat.1000864","article-title":"The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis","volume":"6","author":"Miller","year":"2010","journal-title":"PLoS Pathog"},{"key":"B128","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/eji.200939583","article-title":"A role for IL-18 in protective immunity against Mycobacterium tuberculosis","volume":"40","author":"Schneider","year":"2010","journal-title":"Eur J Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1128\/IAI.68.5.2962-2970.2000","article-title":"Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice","volume":"68","author":"Maeurer","year":"2000","journal-title":"Infect Immun"},{"key":"B131","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"Mackall","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1086\/653827","article-title":"Coadministration of interleukins 7 and 15 with bacille Calmette-Guerin mounts enduring T cell memory response against Mycobacterium tuberculosis","volume":"202","author":"Singh","year":"2010","journal-title":"J Infect Dis"},{"key":"B133","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18","volume":"73","author":"Gracie","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B134","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/IAI.67.5.2585-2589.1999","article-title":"Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice","volume":"67","author":"Sugawara","year":"1999","journal-title":"Infect Immun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1046\/j.1432-1033.2002.03338.x","article-title":"The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains","volume":"269","author":"Shimada","year":"2002","journal-title":"Eur J Biochem"},{"key":"B136","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1074\/jbc.M709483200","article-title":"How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction","volume":"283","author":"Nelson","year":"2008","journal-title":"J Biol Chem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","article-title":"Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-naive adults: a randomized, active-controlled, first-in-human phase 1 trial","volume":"7","author":"Hoft","year":"2016","journal-title":"EBioMedicine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1128\/IAI.71.5.2933-2937.2003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit","volume":"71","author":"Biet","year":"2003","journal-title":"Infect Immun"},{"key":"B140","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1016\/S0264-410X(03)00295-0","article-title":"Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA","volume":"21","author":"Marinaro","year":"2003","journal-title":"Vaccine"},{"key":"B141","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vaccine.2008.10.034","article-title":"Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells","volume":"27","author":"Badell","year":"2009","journal-title":"Vaccine"},{"key":"B143","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/QAD.0b013e3282f3ca57","article-title":"Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope","volume":"22","author":"Barnett","year":"2008","journal-title":"AIDS"},{"key":"B144","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1586\/14760584.2.2.285","article-title":"Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines","volume":"2","author":"Peppoloni","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B148","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/CVI.00015-11","article-title":"Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens","volume":"18","author":"Johansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","article-title":"BCG Deltazmp1 vaccine induces enhanced antigen specific immune responses in cattle","volume":"32","author":"Khatri","year":"2014","journal-title":"Vaccine"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/erv.12.94","article-title":"Prime-boost approaches to tuberculosis vaccine development","volume":"11","author":"Dalmia","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"B151","doi-asserted-by":"publisher","first-page":"19947","DOI":"10.18632\/oncotarget.15256","article-title":"Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"},{"key":"B152","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"B153","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"key":"B154","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1016\/j.vaccine.2017.07.073","article-title":"A novel nanoemulsion vaccine induces mucosal interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice","volume":"35","author":"Ahmed","year":"2017","journal-title":"Vaccine"},{"key":"B155","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.vaccine.2009.10.114","article-title":"Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen","volume":"28","author":"Skeiky","year":"2010","journal-title":"Vaccine"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e39909","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity","volume":"7","author":"Billeskov","year":"2012","journal-title":"PLoS One"},{"key":"B158","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"key":"B159","doi-asserted-by":"publisher","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ebiom.2017.07.005","article-title":"A multistage subunit vaccine effectively protects mice against primary progressive tuberculosis, latency and reactivation","volume":"22","author":"Ma","year":"2017","journal-title":"EBioMedicine"},{"key":"B161","doi-asserted-by":"publisher","first-page":"e0168521","DOI":"10.1371\/journal.pone.0168521","article-title":"Immunogenicity and protective efficacy of the DAR-901 booster vaccine in a murine model of tuberculosis","volume":"11","author":"Lahey","year":"2016","journal-title":"PLoS One"},{"key":"B162","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e00245-17","DOI":"10.1128\/IAI.00245-17","article-title":"Listeria-vectored vaccine expressing the Mycobacterium tuberculosis 30 kDa major secretory protein via the constitutively active prfA* regulon boosts BCG efficacy against tuberculosis","volume":"85","author":"Jia","year":"2017","journal-title":"Infect Immun"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e72745","DOI":"10.1371\/journal.pone.0072745","article-title":"Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice","volume":"8","author":"Xin","year":"2013","journal-title":"PLoS One"},{"key":"B165","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.vaccine.2012.11.042","article-title":"Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model","volume":"31","author":"Cervantes-Villagrana","year":"2013","journal-title":"Vaccine"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ymthe.2017.02.018","article-title":"Sendai virus mucosal vaccination establishes lung-resident memory CD8 T cell immunity and boosts BCG-primed protection against TB in mice","volume":"25","author":"Hu","year":"2017","journal-title":"Mol Ther"},{"key":"B167","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tube.2016.10.002","article-title":"Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis","volume":"101","author":"Saqib","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B168","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/IAI.00685-08","article-title":"Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis","volume":"77","author":"Tchilian","year":"2009","journal-title":"Infect Immun"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2016.01.006","article-title":"Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice","volume":"93","author":"Yang","year":"2016","journal-title":"Microb Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T09:49:56Z","timestamp":1603792196000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2018.00121"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00121","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"article-number":"121"}}